Altered relationship between hippocampal glutamate levels and striatal dopamine function in subjects at ultra high risk of psychosis

Biological Psychiatry

Volumn 68, Issue 7, 2010, Pages 599-602

  Stone, James M ^a,b   Howes, Oliver D ^a,b   Egerton, Alice ^a,b   Kambeitz, Joseph ^a   Allen, Paul ^a   Lythgoe, David J ^a   O'Gorman, Ruth L ^a   McLean, Mary A ^c   Barker, Gareth J ^a   McGuire, Philip ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

ARMS; dopamine; glutamate; imaging; magnetic resonance spectroscopy; positron emission tomography; psychosis; schizophrenia; UHR

Indexed keywords

DOPA; DOPAMINE; GLUTAMIC ACID;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOPAMINE UPTAKE; HIGH RISK PATIENT; HIPPOCAMPUS; HUMAN; LINEAR REGRESSION ANALYSIS; MENTAL HEALTH; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; PSYCHOSIS; SPEECH DISORDER; STRIATE CORTEX;

BRAIN MAPPING; CORPUS STRIATUM; DIHYDROXYPHENYLALANINE; DOPAMINE; GLUTAMIC ACID; HIPPOCAMPUS; HUMANS; LINEAR MODELS; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, BIOLOGICAL; POSITRON-EMISSION TOMOGRAPHY; PROTONS; PSYCHOTIC DISORDERS; RADIOPHARMACEUTICALS; RISK;

EID: 77956934157     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2010.05.034     Document Type: Article

References (19)

1. A. Carlsson, N. Waters, S. Holm-Waters, J. Tedroff, M. Nilsson, and M.L. Carlsson Interactions between monoamines, glutamate, and GABA in schizophrenia: New evidence Annu Review Pharmacol Toxicol 41 2001 237 260
2. J.E. Lisman, J.T. Coyle, R.W. Green, D.C. Javitt, F.M. Benes, S. Heckers, and A.A. Grace Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia Trends Neurosci 31 2008 234 242
3. P. McGuire, O.D. Howes, J. Stone, and P. Fusar-Poli Functional neuroimaging in schizophrenia: Diagnosis and drug discovery Trends Pharmacol Sci 29 2008 91 98
4. D.J. Lodge, and A.A. Grace The hippocampus modulates dopamine neuron responsivity by regulating the intensity of phasic neuron activation Neuropsychopharmacology 31 2006 1356 1361
5. D.J. Lodge, and A.A. Grace Gestational methylazoxymethanol acetate administration: A developmental disruption model of schizophrenia Behav Brain Res 204 2009 306 312
6. J.M. Stone, P.D. Morrison, and L.S. Pilowsky Glutamate and dopamine dysregulation in schizophreniaa synthesis and selective review J Psychopharmacol 21 2007 440 452
7. L.S. Pilowsky, R.A. Bressan, J.M. Stone, K. Erlandsson, R.S. Mulligan, J.H. Krystal, and P.J. Ell First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients Mol Psychiatry 11 2006 118 119
8. A.J. Law, and J.F. Deakin Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses Neuroreport 12 2001 2971 2974
9. L.J. Phillips, A.R. Yung, and P.D. McGorry Identification of young people at risk of psychosis: Validation of Personal Assessment and Crisis Evaluation Clinic intake criteria Aust N Z J Psychiatry 34 2000 S164 S169
10. C. Pantelis, D. Velakoulis, P.D. McGorry, S.J. Wood, J. Suckling, and L.J. Phillips Neuroanatomical abnormalities before and after onset of psychosis: A cross-sectional and longitudinal MRI comparison Lancet 361 2003 281 288
11. R. Hurlemann, F. Jessen, M. Wagner, I. Frommann, S. Ruhrmann, and A. Brockhaus Interrelated neuropsychological and anatomical evidence of hippocampal pathology in the at-risk mental state Psychol Med 38 2008 843 851
12. J.M. Stone, F. Day, H. Tsagaraki, I. Valli, M.A. McLean, and D.J. Lythgoe Glutamate dysfunction in people with prodromal symptoms of psychosis: Relationship to gray matter volume Biol Psychiatry 66 2009 533 539 Nos. 6
13. O.D. Howes, A.J. Montgomery, M.C. Asselin, R.M. Murray, I. Valli, and P. Tabraham Elevated striatal dopamine function linked to prodromal signs of schizophrenia Arch Gen Psychiatry 66 2009 13 20
14. S.J. Wood, D. Kennedy, L.J. Phillips, M.L. Seal, M. Yucel, and B. Nelson Hippocampal pathology in individuals at ultra-high risk for psychosis: A multi-modal magnetic resonance study Neuroimage 52 2010 62 68
15. S.W. Provencher Estimation of metabolite concentrations from localized in vivo proton NMR spectra Magn Reson Med 30 1993 672 679
16. D. Martinez, M. Slifstein, A. Broft, O. Mawlawi, D.R. Hwang, and Y. Huang Imaging human mesolimbic dopamine transmission with positron emission tomography Part II: Amphetamine-induced dopamine release in the functional subdivisions of the striatum J Cereb Blood Flow Metab 23 2003 285 300
17. D.P. Friedman, J.P. Aggleton, and R.C. Saunders Comparison of hippocampal, amygdala, and perirhinal projections to the nucleus accumbens: Combined anterograde and retrograde tracing study in the macaque brain J Comp Neurol 450 2002 345 365
18. R. Ihaka, and R. Gentleman R: A language for data analysis and graphics J Comput Graph Stat 5 1996 299 314
19. G.E. Tsai, and P.Y. Lin Strategies to enhance N-methyl-D-aspartate receptor-mediated neurotransmission in schizophrenia, a critical review and Meta-analysis Curr Pharm Des 16 2010 522 537